Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

ClinicalTrials.gov ID: NCT00106288

Public ClinicalTrials.gov record NCT00106288. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 11:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double Blind, Comparative, Randomized Study to Evaluate the Efficacy and Safety of Micafungin (FK463) Versus Liposomal Amphotericin B (AmBisome) in the Treatment of Invasive Candidiasis and Candidemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the efficacy and safety of micafungin (FK463) versus liposomal amphotericin B (AmBisome) in treating neutropenic and non-neutropenic patients with confirmed invasive candidiasis or candidemia. Enrollment will include adult and pediatric patients.

Study identification

NCT ID
NCT00106288
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
637 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2003 (Type not available)
Primary completion
Dec 2005 (Actual)
Completion
Dec 2005 (Actual)
Last update posted
Sep 18, 2014

2003 – 2005

United States locations

U.S. sites
27
U.S. states
18
U.S. cities
22
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294-0006 —
Not listed Orange California 92868 —
Not listed Denver Colorado 80218 —
Not listed Washington D.C. District of Columbia 20010-2970 —
Not listed Jacksonville Florida 32207 —
Not listed Atlanta Georgia 30322 —
Not listed Hinsdale Illinois 60521 —
Not listed Maywood Illinois 60153 —
Not listed Kansas City Kansas 66160 —
Not listed Lexington Kentucky 40536-0084 —
Not listed Baltimore Maryland 21201-1595 —
Not listed Boston Massachusetts 02115 —
Not listed Boston Massachusetts 02211 —
Not listed Detroit Michigan 48201 —
Not listed Minneapolis Minnesota 55455 —
Not listed New York New York 10021 —
Not listed New York New York 10029 —
Not listed New York New York 10032 —
Not listed Rochester New York 14642 —
Not listed Valhalla New York 10595 —
Not listed Durham North Carolina 27710 —
Not listed Philadelphia Pennsylvania 19104 —
Not listed Philadelphia Pennsylvania 19107 —
Not listed Philadelphia Pennsylvania 19140 —
Not listed Houston Texas 77030 —
Not listed San Antonio Texas 78229-3900 —
Not listed Provo Utah 84604 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00106288, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 18, 2014 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00106288 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →